Roche Donates 100 Million Yuan’s Worth Of Antitumor Drugs
This article was originally published in PharmAsia News
With the approach of the World No Tobacco Day on 31 May, Shanghai Roche Pharmaceuticals has donated almost 100 million yuan's worth of its antitumor product Tarceva at a drug donation charity event co-organized by China Charity Federation, Cancer Foundation of China and Chinese Anti-Cancer Association. The donated drug will be given to financially strapped patients with advanced non-small-cell lung cancer. Patients' application will be officially accepted from this October. (Click here for more - Chinese Language)
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.